1News 1News: your global news briefing, coming soon on iOS & Android
Coming Soon
Back to Business
Guggenheim reiterates Absci stock rating on endometriosis trial delay
Business September 28, 2026 at 6:23 AM

Guggenheim reiterates Absci stock rating on endometriosis trial delay

Investing.com
Read the full story at Investing.com
More Stories
LMP Capital And Income Fund Inc. Q2 2026 Commentary
Business
LMP Capital And Income Fund Inc. Q2 2026 Commentary
🇺🇸 Seeking Alpha 29m ago
Franklin Equity Income Fund Q2 2026 Commentary
Business
Franklin Equity Income Fund Q2 2026 Commentary
🇺🇸 Seeking Alpha 34m ago
Franklin Small-Mid Cap Growth Fund Q2 2026 Commentary
Business
Franklin Small-Mid Cap Growth Fund Q2 2026 Commentary
🇺🇸 Seeking Alpha 34m ago
1News
Your world briefing, in your pocket

Curated news from 12 countries and 10 languages. Coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play